Development of diabetes in non-obese diabetic mice promotes Chlamydia pneumoniae dissemination from lung to peripheral blood

International Journal of Experimental Pathology

Volumn 87, Issue 2, 2006, Pages 121-129

  Yamaguchi, Hiroyuki ^a,c   Oshio, Ichiro ^b   Osaki, Takako ^b   Kurata, Satoru ^b   Yamamoto, Yoshimasa ^a   Kamiya, Shigeru ^b  

^a OSAKA UNIVERSITY   (Japan)

^b KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chlamydia pmeumoniae; Diabetes; Dissemination; Inclusion forming units; Non obese diabetic mice; Peripheral blood mononuclear cells; Real time reverse transcription polymerase chain reaction

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; CHLAMYDIA MONOCLONAL ANTIBODY; FLUORESCEIN ISOTHIOCYANATE; HYDROCORTISONE; MONOCLONAL ANTIBODY; PRIMER RNA; RIBOSOME RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN DETECTION; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM DETECTION; BLOOD; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; IMMUNOHISTOCHEMISTRY; INOCULATION; LUNG INFECTION; MOUSE; MOUSE STRAIN; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; ANTIGENS, BACTERIAL; CELLS, CULTURED; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; DIABETES MELLITUS, EXPERIMENTAL; DISEASE SUSCEPTIBILITY; FLUORESCENT ANTIBODY TECHNIQUE; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; LUNG; MICE; MICE, INBRED ICR; MICE, INBRED NOD; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33645361434     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.0959-9673.2006.00468.x     Document Type: Article

References (38)

1. Adorini L. Aloisi F. Galbiati F. et al. 1997 Targeting IL-12, the key cytokine driving Th1-mediated autoimmune diseases. Chem. Immunol. 68 175 197.
2. Altannavch T. Roubalova K. Broz J. Hruba D. Andel M. 2003 Serological markers of Chlamydia pneumoniae, cytomegalovirus and Helicobacter pylori infection in diabetic and non-diabetic patients with unstable angina pectoris. Cent. Eur. J. Public. Health. 11 102 106.
3. Bach J.F. 1994 Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr. Rev. 15 516 542.
4. Berger M. Schroder B. Daeschlein G. et al. 2000 Chlamydia pneumoniae DNA in non-coronary atherosclerotic plaques and circulating leukocytes. J. Lab. Clin. Med. 136 194 200.
5. Blasi F. Boman J. Esposito G. et al. 1999 Chlamydia pneumoniae DNA detection in peripheral blood mononuclear cells is predictive of vascular infection. J. Infect. Dis. 180 2074 2076.
6. Blessing E. Lin T. Campbell L.A. Rosenfeld M.E. Lloyd D. Kuo C.C. 2000 Chlamydia pneumoniae induces inflammatory changes in the heart and aorta of normocholesterolemic C57BL/6J mice. Infect. Immun. 68 4765 4768.
7. Bodetti T.J. Timms P. 2000 Detection of Chlamydia pneumoniae DNA and antigen in the circulating mononuclear cell fractions of humans and koalas. Infect. Immun. 68 2744 2747.
8. Christen U. Benke D. Wolfe T. et al. 2004 Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradient. J. Clin. Invest. 113 74 84.
9. Esposito G. Blasi F. Allegra L. et al. 1999 Demonstration of viable Chlamydia pneumoniae in atherosclerotic plaques of carotid arteries by reverse transcriptase polymerase chain reaction. Ann. Vasc. Surg. 13 421 425.
10. Feigin R.D. Shearer W.T. 1975 Opportunistic infection in children. II. In the Compromised Host. J. Pediatr. 87 677 694.
11. Fong I.W. Chiu B. Viira E. Fong M.W. Jang D. Mahony J. 1997 Rabbit model for Chlamydia pneumoniae infection. J. Clin. Microbiol. 35 48 52.
12. Gaydos C.A. Summersgill J.T. Sahney N.N. RamireZ. J.A. Quinn T.Q. 1996 Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect. Immun. 64 1614 1620.
13. Hammerschlag M.R. Chirgwin K. Roblin P.M. et al. 1992 Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin. Infect. Dis. 14 178 182.
14. Haranaga S. Ikejima H. Yamaguchi H. Friedman H. Yamamoto Y. 2002 Analysis of Chlamydia pneumoniae growth in cells by reverse transcription-PCR targeted to bacterial gene transcripts. Clin. Diagn. Lab. Immunol. 9 313 319.
15. Haranaga S. Yamaguchi H. Leparc G.F. Friedman H. Yamamoto Y. 2001 Detection of Chlamydia pneumoniae antigen in PBMNCs of healthy blood donors. Transfusion 41 1114 1118.
16. Harper A. Pogson C.I. Jones M.L. Pearce J.H. 2000 Chlomydial development is adversely affected by minor changes in amino acid supply, blood plasma amino acid levels, and glucose deprivation. Infect. Immun. 68 1457 1464.
17. Hartemann A.H. Richard M.F. Boitard C. 1999 ) Absence of significant Th2 response in diabetes-prone non-obese diabetic (NOD) mice.
18. Iliescu E.A. Fiebig M.F. Morton A.R. Sankar-Mistry P. 2000 Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in peritoneal dialysis patients. Perit. Dial. Int. 20 722 726.
19. Johnson R.A. 2000 The immune compromised host in the twenty-first century: management of mucocutaneous infections. Semin. Cutan. Med. Surg. 19 19 61.
20. Kikutani H. Makino S. 1992 The murine autoimmune diabetes model: NOD and related strains. Adv. Immunol. 51 285 322.
21. Laitinen K. Laurila A.L. Leinonen M. Saikku P. 1996 Reactivation of Chlamydia pneumoniae infection in mice by cortisone treatment. Infect. Immun. 64 1488 1490.
22. Makino S. Kunimoto K. Muraoka Y. Mizushima Y. Katagiri K. Tochino Y. 1980 Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 29 1 13.
23. Malinverni R. Kuo C.C. Campbell L.A. Grayston J.T. 1995 Reactivation of Chlamydia pneumoniae lung infection in mice by cortison. J. Infect. Dis. 172 593 594.
24. Moazed T.C. Kuo C.C. Gryston J.T. Campbell L.A. 1998 Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J. Infect. Dis. 177 1322 1325.
25. Muller J. Moller D.S. Kjaer M. Nyvad O. Larsen N.A. Pedersen E.B. 2003 Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in healthy control subjects and patients with diabetes mellitus, acute coronary syndrome, stroke, and arterial hypertension. Scand. J. Infect. Dis. 35 704 712.
26. Orrett F.A. 2000 Fatal Bacillus cereus bacteremia in a patient with diabetes. J. Natl. Med. Assoc. 92 206 208.
27. Ossewaard J.M. de Vries A. Bestebroer T. Angulo A.F. 1996 Application of a Mycoplasma group-specific PCR for monitoring decontamination of Mycoplasma-infected Chlamydia sp. Strains. Appl. Environ. Microbiol. 62 328 331.
28. Ramirez J.A. 1996 Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis: the Chlamydia pneumoniae/ Atherosclerosis Study Group. Ann. Intern. Med. 192 3397 3400.
29. Ross R. 1999 Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 340 115 126.
30. Rottenberg M.E. Gigliotti-Rothfuchs A. Wigzell H. 2002 The role of IFN γ in the outcome of chlamydial infection. Curr. Opin. Immunol. 14 444 451.
31. Serreze D.V. Ottendorfer E.W. Ellis T.M. Gauntt C.J. Atkinson M.A. 2000 Acceleration of type 1 diabetes by a coxsackivirus infection requires a preexisiting critical mass of autoreactive T-cells in pancreatic islets. Diabetes 49 708 711.
32. Takano R. Yamaguchi H. Sugimoto S. Nakamura S. Friedman H. Yamamoto Y. 2005 Cytokine response of lymphocytes persistently infected with Chlamydia pneumoniae. Curr. Microbiol. 50 160 166.
33. Tsumurs N. Emre U. Roblin P. Hammerschlag M.R. 1996 Effect of hydrocortisone succinate on growth of Chlamydia pneumoniae in vitro. J. Clin. Microbiol. 34 2379 2381.
34. Willerson J.T. Ridker P.M. 2004 Inflammation as a cardiovascular risk factor. Circulation 109 Suppl. II II 2 II 10.
35. Yamaguchi H. Yamada M. Uruma T. et al. 2004 Prevalence of viable Chlamydia pneumoniae in peripheral blood mononuclear cells of healthy blood donors. Transfusion 44 1071 1078.
36. Yamamoto Y. Friedman H. 1996 Drugs of Abuse, Immunity and Infections. In: Steroids and Infection, Psychoneuroimmunology, Stress, and Infection, pp. 173 194 (eds. Friedman H. Klein T.W. Friedman A.L.. New York CRC Press.
37. Yang Z.P. Kuo C.C. Grayston J.T. 1993 A mouse model of Chlamydia pneumoniae strain TWAR pneumonitis. Infect. Immun. 61 2037 2040.
38. Yang Z.P. Kuo C.C. Grayston J.T. 1995 Systemic dissemination of Chlamydia pneumoniae following intranasal inoculation. J. Infect. Dis. 177 736 738.